These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21690580)

  • 1. ACP Journal Club. Quadruple-drug therapy was better than triple-drug therapy for eradicating Helicobacter pylori in adults.
    Talley NJ
    Ann Intern Med; 2011 Jun; 154(12):JC6-2. PubMed ID: 21690580
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori.
    de Boer WA; Driessen WM; Potters VP; Tytgat GN
    Am J Gastroenterol; 1994 Nov; 89(11):1993-7. PubMed ID: 7942724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.
    Fischbach LA; van Zanten S; Dickason J
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1071-82. PubMed ID: 15569109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q; Pan Y; Zhang L; Xiao SD
    Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronidazole-based quadruple versus standard triple therapy: which is better as first-line therapy for Helicobacter pylori eradication?
    Suzuki H; Matsuzaki J; Hibi T
    Expert Rev Clin Pharmacol; 2011 Sep; 4(5):579-82. PubMed ID: 22114887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.
    Zullo A; De Francesco V; Scaccianoce G; Hassan C; Panarese A; Piglionica D; Panella C; Morini S; Ierardi E
    Dig Liver Dis; 2005 Jul; 37(7):496-500. PubMed ID: 15975536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.
    Fischbach L; Evans EL
    Aliment Pharmacol Ther; 2007 Aug; 26(3):343-57. PubMed ID: 17635369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study.
    Zullo A; De Francesco V; Scaccianoce G; Manes G; Efrati C; Hassan C; Maconi G; Piglionica D; Cannaviello C; Panella C; Morini S; Ierardi E
    Dig Liver Dis; 2007 Sep; 39(9):806-10. PubMed ID: 17644057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy.
    Kim SY; Lee SW; Hyun JJ; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Choi JH
    J Clin Gastroenterol; 2013 Jan; 47(1):21-4. PubMed ID: 22647826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Sep; 34(6):604-17. PubMed ID: 21745241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori treatment: is sequential or quadruple therapy the answer?
    Vakil N
    Rev Gastroenterol Disord; 2008; 8(2):77-82. PubMed ID: 18641590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection.
    Yee YK; Cheung TK; Chu KM; Chan CK; Fung J; Chan P; But D; Hung I; Chan AO; Yuen MF; Hsu A; Wong BC
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1063-7. PubMed ID: 17877513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection.
    Cheon JH; Kim N; Lee DH; Kim JM; Kim JS; Jung HC; Song IS
    Helicobacter; 2006 Feb; 11(1):46-51. PubMed ID: 16423089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori eradication with ecabet sodium, omeprazole, amoxicillin, and clarithromycin versus bismuth, omeprazole, amoxicillin, and clarithromycin quadruple therapy: a randomized, open-label, phase IV trial.
    Liang J; Li J; Han Y; Xia J; Yang Y; Li W; Zhang S; Wu Y; Yuan Y; Li Z; Du Y; Chen M; Chen B; Jiang B; Bai Y; Wen Q; Wu K; Fan D
    Helicobacter; 2012 Dec; 17(6):458-65. PubMed ID: 23066868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
    Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
    Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
    Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis.
    Marko D; Calvet X; Ducons J; Guardiola J; Tito L; Bory F;
    Helicobacter; 2005 Feb; 10(1):22-32. PubMed ID: 15691312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of Helicobacter pylori: an open-label control study in Chinese patients.
    Wang Z; Wu S
    Singapore Med J; 2012 Apr; 53(4):273-6. PubMed ID: 22511052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.